Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

A new era in haemophilia approaches. Yesterday’s big news came from two rival developing gene therapies which could represent a cure for haemophilia – Spark Therapeutics and BioMarin. ... BioMarin meanwhile also provided long-term data on its

Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more

Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more. ... records. NEW RARE DISEASE APPROVAL. BioMarin sees blockbuster potential for newly-approved Palynziq.

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

More encouraging data for Spark and Pfizer’s potential haemophilia B cure Here BioMarin looks to have the edge, with its valoctocogene roxaparvovec or ‘valrox’, formerly BMN 270 producing superior results to Spark’s own SPK-8011.

BioMarin ups the ante for pivotal haemophilia gene therapy trial

BioMarin ups the ante for pivotal haemophilia gene therapy trial BioMarin ups the ante for pivotal haemophilia gene therapy trial. Adds another 90 patients to the GENEr8-1 registration study. ... There were also dramatic improvements in quality of life which BioMarin said stemmed from “cessation of bleeding, freedom

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics